Christopher Manseau, MD
Orthopaedic Surgery · Ocala, FLNPI 1912904780
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,923 of the $26,598 with a category attached, or 71.1%. 9 manufacturers reported payments, led by Medical Device Business Services, Inc. at 48.8% of the total.
Across 73 payments — averaging $364.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$13K
- FX Shoulder Solutions, Inc$10K
- Stryker$1K
- Johnson & Johnson$1K
- Depuy Synthes Products, Inc.$900
- Smith+Nephew$83
- plus $122 from 3 others
Across 1 payment — averaging $1250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$1K
What the payments were for
- Consulting fees$18,92371%
- Travel & lodging$4,88718%
- Food & beverage$2,78810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 19 | $12,992 |
| FX Shoulder Solutions, Inc | 4 | $9,936 |
| Stryker | 19 | $1,332 |
| Johnson & Johnson(2 entities) | 21 | $1,234 |
| Depuy Synthes Products, Inc. | 1 | $900 |
| Smith+Nephew | 4 | $83 |
| Heraeus Medical, LLC. | 3 | $54 |
| Integra Lifesciences Corporation | 1 | $52 |
| Pacira Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,598 in reported general payments places this provider in the 75th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 194 | $3,504 |
| Methocarbamol | 268 | $3,348 |
| Celecoxib | 178 | $1,725 |
| Pregabalin | 168 | $1,249 |
| Ondansetron Hcl | 214 | $1,173 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 63 | $508 |
| Prednisone | 84 | $496 |
| Doxycycline Hyclate | 26 | $345 |
| Methylprednisolone | 14 | $90 |
| Gabapentin | 17 | $46 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Ocala
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.